Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Net Margin Over TimeStable
Percentile Rank57
3Y CAGR-4.1%
5Y CAGR-5.3%
Year-over-Year Change
Net income as a percentage of revenue
3Y CAGR
-4.1%/yr
vs -0.5%/yr prior
5Y CAGR
-5.3%/yr
Consistent
Acceleration
-3.6pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 31.41% | +1.1% |
| 2024 | 31.07% | +3.1% |
| 2023 | 30.14% | -15.4% |
| 2022 | 35.64% | -29.1% |
| 2021 | 50.25% | +21.5% |
| 2020 | 41.35% | +28.1% |
| 2019 | 32.26% | -11.4% |
| 2018 | 36.42% | +78.5% |
| 2017 | 20.41% | +10.8% |
| 2016 | 18.42% | - |